Drug–induced liver injury appears more common in patients on tuberculosis therapy with chronic hepatitis C virus infection.

Fatty acid abnormalities and EFAD biomarkers are common in patients with cystic fibrosis who have severe CFTR genotypes.

Continuous positive airway pressure (CPAP) termination rates among patients with OSA are affected by geographic disparities.

A new alert from the FDA warns that some sensors from Abbott may give incorrect blood sugar readings, which could lead to unsafe treatment decisions.

Inhaled Technosphere insulin (TI) vs subcutaneous RAA did not meet the noninferiority margin for glycated HbA1c in youth with diabetes.

The FDA is facing even more leadership changes as drug regulator Dr Richard Pazdur prepares to retire at the end of the month.

Although many definitions have been developed to diagnose BPD, none are consistently accurate in predicting long-term outcomes.

A severe mosquito-borne virus outbreak in Cuba has led to dozens of deaths since midsummer, including many young children.

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Long-term exposure to black carbon is associated with an increased risk for developing asthma and chronic obstructive pulmonary disease.

CHEST guidelines on biologic management in severe adult asthma offers recommendations on choosing and switching among biologic therapies.